Our lab is dedicated to researching the causes, diagnosis, and future treatments of Alzheimer’s disease (AD). We use various techniques to directly measure the pathology and pathophysiology of AD in humans. Our team employs a wide range of methods, from basic applications like the quantitative measurement of stable-isotope labeled peptides, to advanced clinical studies focused on diagnostic and therapeutic biomarkers for AD.
Featured

Tracy Family SILQ Center
Expanding knowledge of proteins associated with Alzheimer’s disease
and other disorders of aging.

SUNBIRD
Study to Understand Novel Biomarkers in Researching Dementia